Enanta Pharmaceuticals, Inc.
Processes for the resolution of benzodiazepin-2-one and benzoazepin-2-one derivatives
Last updated:
Abstract:
The present invention relates to processes and intermediates useful in the preparation of biologically active molecules, especially in the synthesis of Respiratory Syncytial Virus (RSV) inhibitors. The present invention also relates to processes and intermediates for the preparation of compounds of Formula (I-0) and Formula (I): ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
14 Nov 2019
Issue date:
1 Dec 2020